

Performance & Innovation !
|
COMPETITIVE AND BUSINESS INTELLIGENCE |
EUROPE EMEA NOTICE DOCUMENTS
|
|
Draft ICH concept paper on pharmaco genomic (PG) biomarker qualification: Format and data standards
This concept paper supports a proposal for a new harmonized ICH guideline on important aspects for the qualification of PG biomarkers. Full document...
Concept paper on Minimum date requirements for an authorisation under exceptional circumstances for vaccines for emergency use against bluetongue
Bluetongue (BT) is a non-contagious, insect-transmitted disease that is caused by BT virus (BTV). It is principally a disease of sheep and other domestic and wild ruminant species. Full document...
Reflection Paper on the Implementation of Directive 2001/82/EC, as amended, in respect to the assessment of environmental risks of veterinary Medicinal Products
Directive 2001/82/EC, as amended by Directive 2004/28/EC [1], includes new provisions regarding the consideration of effects on the environment in the benefit/risk assessment of veterinary medicinal products and on the data requirements regarding such effects. Full document...
Reflection paper on consideration of adjuvants and preservatives under Council regulation (EEC) No 2377/90 laying down a community procedure for the establishment od Maximum Residue Limits of veterinary medicinal products in foodstuffs of animal origin
Adjuvants are excipients used in immunological products due to their capacity to increase and/or prolong the immune response to the active ingredient. This activity is a matter separate from their potential pharmacological activity. Full document...
Reflection Paper on pharmacogenomic samples, testing and data handling
This paper addressed reflections on some aspects surrounding pre-analytical, analytical and postanalytical steps surrounding PGx samples, testing and data handling, key for the scientific reliability of PGx data submitted for regulatory evaluation. Full document...
Comments received during the public consultation on Reflection paper on the risks associated with furocoumarins contained in preparations of Angelica archangelica L.
Comments received during the public consultation on Reflection paper on the risks associated with furocoumarins contained in preparations of Angelica archangelica L. Full document...
Reflection Paper on the risks associated with furocoumarins contained in preparations of Angelica archangelica L.
This reflection paper focuses on coumarin-derivatives present in Angelica archangelica L., as these substances are the most relevant constituents for phototoxicity. In addition to these constituents, there are a large number of other compounds, which have been found e.g. in the essential oil. The safety of these constituents is not addressed in this paper. Full document...
<<< 1 2 3 4 5 6 7 8 9 >>> |
|
|